重新定义多发性硬化症的进展
Jeffrey Lambe1, Daniel Ontaneda
1Mellen Center for Multiple Sclerosis Treatment and Research, Neurology Department, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
Current opinion in neurology
|April 8, 2025
概括
多发性硬化症 (MS) 的进展很早就开始,由炎症和神经退行驱动. 识别这些早期的渐进性成分对于复发性复发性多发性硬化症 (RRMS) 的个性化治疗策略至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
- 临床过程定义正在发展,包括在复发的同时进行进展.
研究的目的:
- 审查多发性硬化症 (MS) 的进展情况.
- 确定驱动多发性硬化症进展的病理机制.
- 提供MS早期渐进性生物学的证据.
主要方法:
- 对有关MS进展的现有文献的审查.
- 对病理机制的分析.
- 检查临床试验数据,包括托莱布鲁替尼.
主要成果:
- 独立于复发的进展对复发性复发性多发性硬化症 (RRMS) 的残疾有显著的贡献.
- 多发性硬化症的进展包括炎症,微质激活,氧化应激和神经退行.
- 这些病理过程在疾病的早期就很明显,并且随着时间的推移而演变.
结论:
- 多发性硬化症的进展是一个连续的过程,可以在RRMS早期检测到.
- 疾病进展的病理驱动因素与残疾相关.
- 个性化治疗策略需要早期识别使用临床措施和生物标志物的渐进性成分.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:15Parkinson's Disease: Overview
342
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
342